Rheumatoid arthritis in 2014: Exciting times for RA research.

about

The Effects of Rituximab on Lipids, Arterial Stiffness and Carotid Intima-Media Thickness in Rheumatoid Arthritis Design, synthesis and evaluation of ()-3-(7-(methyl(7-pyrrolo[2,3-]pyrimidin-4-yl)amino)-5-azaspiro[2.4]heptan-5-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor

P2860

Q36509932-BFD7AC7C-1A71-45F3-8763-C932B8557104 Q57557905-67D1D1BC-A706-4D1E-A806-787A529E52FA

P2860

Rheumatoid arthritis in 2014: Exciting times for RA research.

Item

http://www.wikidata.org/entity/Q39068822

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Rheumatoid arthritis in 2014: Exciting times for RA research.

@en

Rheumatoid arthritis in 2014: Exciting times for RA research.

@en-gb

Rheumatoid arthritis in 2014: Exciting times for RA research.

@nl

type

Item

label

Rheumatoid arthritis in 2014: Exciting times for RA research.

@en

Rheumatoid arthritis in 2014: Exciting times for RA research.

@en-gb

Rheumatoid arthritis in 2014: Exciting times for RA research.

@nl

prefLabel

Rheumatoid arthritis in 2014: Exciting times for RA research.

@en

Rheumatoid arthritis in 2014: Exciting times for RA research.

@en-gb

Rheumatoid arthritis in 2014: Exciting times for RA research.

@nl

P1476

Rheumatoid arthritis in 2014: Exciting times for RA research.

@en

P2860

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Denervation protects limbs from inflammatory arthritis via an impact on the microvasculature.

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

New therapies for treatment of rheumatoid arthritis.

Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis.

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.

P2888

nrrheum.2014.216

P304

69-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRRHEUM.2014.216

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul Emery

P577

2014-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010265809

http://www.w3.org/2001/XMLSchema#string

P698

25536484

http://www.w3.org/2001/XMLSchema#string

Rheumatoid arthritis in 2014: Exciting times for RA research.

about

P2860

P2860

Rheumatoid arthritis in 2014: Exciting times for RA research.

description

name

type

label

prefLabel

P1433

P1476

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698